Please use this identifier to cite or link to this item:
|Title:||Increased DNA methylation variability in type 1 diabetes across three immune effector cell types||Authors:||Paul, Dirk S.
Teschendorff, Andrew E.
Dang, Mary A.N.
Hawa, Mohammed I.
Fouts, Alexandra R.
Cheung, Warren A.
Gut, Ivo G
Ouwehand, Willem H.
Hofer, Sabine E.
Boehm, Bernhard O.
Elding Larsson, Helena
Steck, Andrea K.
Rakyan, Vardhman K.
Leslie, R. David
|Issue Date:||2016||Source:||Paul, D. S., Teschendorff, A. E., Dang, M. A., Lowe, R., Hawa, M. I., Ecker, S., . . . Leslie, R. D. (2016). Increased DNA methylation variability in type 1 diabetes across three immune effector cell types. Nature Communications, 7, 13555-. doi:10.1038/ncomms13555||Series/Report no.:||Nature Communications||Abstract:||The incidence of type 1 diabetes (T1D) has substantially increased over the past decade, suggesting a role for non-genetic factors such as epigenetic mechanisms in disease development. Here we present an epigenome-wide association study across 406,365 CpGs in 52 monozygotic twin pairs discordant for T1D in three immune effector cell types. We observe a substantial enrichment of differentially variable CpG positions (DVPs) in T1D twins when compared with their healthy co-twins and when compared with healthy, unrelated individuals. These T1D-associated DVPs are found to be temporally stable and enriched at gene regulatory elements. Integration with cell type-specific gene regulatory circuits highlight pathways involved in immune cell metabolism and the cell cycle, including mTOR signalling. Evidence from cord blood of newborns who progress to overt T1D suggests that the DVPs likely emerge after birth. Our findings, based on 772 methylomes, implicate epigenetic changes that could contribute to disease pathogenesis in T1D.||URI:||https://hdl.handle.net/10356/89962
|DOI:||10.1038/ncomms13555||Rights:||© 2016 The Author(s) (Published by Nature Publishing Group). This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||LKCMedicine Journal Articles|
Files in This Item:
|Increased DNA methylation variability in type 1 diabetes across three immune effector cell types.pdf||4.06 MB||Adobe PDF|
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.